| You are here: Home: BCU Surgeons Vol.2 Issue 4: David N Krag, MD, FACS: Select publications
Select publications
Recent publications on SLNB
Bevilacqua JL et al. A selection algorithm for internal mammary sentinel lymph node biopsy in breast cancer. Eur J Surg Oncol 2002;28(6):603-14. Abstract
Blanchard DK et al. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 2003;138(5):482-7;discussion 487-8. Abstract
Blessing WD et al. A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping. Am J Surg 2002;184(4):341-5. Abstract
Chua B et al. Outcomes of sentinel node biopsy for breast cancer in British Columbia, 1996 to 2001. Am J Surg 2003;185(2):118-26. Abstract
den Bakker MA et al. Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance. J Clin Pathol 2002;55(12):932-5. Abstract
Fant JS et al. Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol 2003;10(2):126-30. Abstract
Guenther JM et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg 2003;138(1):52-6. Abstract
Jakub JW et al. Current status of sentinel lymph node mapping and biopsy: Facts and controversies. Oncologist 2003;8(1):59-68. Abstract
Mamounas EP. Sentinel lymph node biopsy after neoadjuvant systemic therapy. Surg Clin North Am 2003;83(4):931-42. Abstract
Moonka R et al. A comparison of rates of lymph node metastases between patients undergoing sentinel and axillary lymphadenectomy. Am J Surg 2002;183(5):558-61. Abstract
Reitsamer R et al. Sentinel lymph node biopsy alone without axillary lymph node dissection -follow up of sentinel lymph node negative breast cancer patients. Eur J Surg Oncol 2003;29(3):221-3. Abstract
Sanidas EE et al. How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer? Am J Surg 2003;185(3):202-10. Abstract
Schijven MP et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003;29(4):341-50. Abstract
Schwartz GF et al. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22, 2001, Philadelphia, Pennsylvania. Hum Pathol 2002;33(6):579-89. Abstract
Simmons R et al. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Ann Surg Oncol 2003;10(3):242-7. Abstract
Singletary SE et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002;20(17):3628-36. Abstract
Swenson KK et al. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 2002;9(8):745-53. Abstract
Veronesi U et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349(6):546-53. Abstract
Wilke LG, Giuliano A. Sentinel lymph node biopsy in patients with early-stage breast cancer: Status of the National Clinical Trials. Surg Clin North Am 2003;83(4):901-10. Abstract
Wong SL et al. Optimal use of sentinel lymph node biopsy versus axillary lymph node dissection in patients with breast carcinoma: A decision analysis. Cancer 2002;95(3):478-87. Abstract
|
